These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12062604)

  • 21. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
    Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
    Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of post-implant edema on prostate brachytherapy treatment margins.
    Reed DR; Wallner K; Ford E; Mueller A; Merrick G; Maki J; Sutlief S; Butler W
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1469-73. PubMed ID: 16137839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique.
    Zelefsky MJ; Yamada Y; Cohen G; Venkatraman ES; Fung AY; Furhang E; Silvern D; Zaider M
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):601-8. PubMed ID: 10974481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
    Smith RP; Beriwal S; Komanduri K; Gibbons E; Benoit R
    Brachytherapy; 2008; 7(3):237-41. PubMed ID: 18599357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is intraoperative nomogram-based overplanning of prostate implants necessary?
    D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura database.
    Orio PF; Merrick GS; Grimm P; Blasko J; Sylvester J; Allen ZA; Butler WM; Chaudhry UU
    Am J Clin Oncol; 2008 Dec; 31(6):523-31. PubMed ID: 19060582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the relationship between pre- and postimplant geometry in prostate low-dose-rate brachytherapy and its correlation with dosimetric quality using the similarity concept.
    Todor DA; Anscher MS; Karlin JD; Hagan MP
    Brachytherapy; 2014; 13(5):471-80. PubMed ID: 25037911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry.
    Butzbach D; Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1196-9. PubMed ID: 11728677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related quality of life after permanent interstitial brachytherapy for prostate cancer: correlation with postimplant CT scan parameters.
    Pinkawa M; Fischedick K; Piroth MD; Gagel B; Borchers H; Jakse G; Eble MJ
    Strahlenther Onkol; 2006 Nov; 182(11):660-5. PubMed ID: 17072524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy.
    Lee WR; Roach M; Michalski J; Moran B; Beyer D
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):457-61. PubMed ID: 12243822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome.
    Stock RG; Stone NN; Lo YC; Malhado N; Kao J; DeWyngaert JK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):899-906. PubMed ID: 11020588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose calculation for permanent prostate implants incorporating spatially anisotropic linearly time-resolving edema.
    Monajemi TT; Clements CM; Sloboda RS
    Med Phys; 2011 Apr; 38(4):2289-98. PubMed ID: 21626964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors predicting for urinary incontinence after prostate brachytherapy.
    McElveen TL; Waterman FM; Kim H; Dicker AP
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1395-404. PubMed ID: 15275725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.
    Lee WR; deGuzman AF; Bare RL; Marshall MG; McCullough DL
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):83-8. PubMed ID: 10656377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of prostate volume on dosimetry results in real-time 125I seed implantation.
    McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of various dosimetric quality indicators in prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):717-24. PubMed ID: 10348304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.
    Chung E; Stenmark MH; Evans C; Narayana V; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1944-8. PubMed ID: 21640498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.